🔎 Trials Near Me

Hjem › Hjertesvigt › Alabama

Hjertesvigt kliniske forsøg i Alabama

23 studier for Hjertesvigt søger deltagere på steder i Alabama.

Byer i Alabama

Officiel studietekst (engelsk)

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Alexander City
  • Research Site, Fairhope
  • Research Site, Huntsville
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 2. okt. 2026 · NCT06307652

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Diagnostic and Medical Clinic, Mobile
  • Mobile Heart Specialists, PC, Mobile
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06424288

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Fairhope
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Advanced Cardiovascular, LLC, Alexander City
  • University of Alabama at Birmingham, Birmingham
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 24. sep. 2026 · NCT06736574

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

  • Cardiology Associates of Mobile, Mobile
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07232030

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • University of Alabama Saint Vincent's Birmingham, Birmingham
  • SEC Clinical Research, Dothan
  • Eastern Shore Research Institute, Fairhope
  • og 1 flere
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Birmingham
  • Research Site, Centreville
  • Research Site, Fairhope
  • og 4 flere
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10004 Fairhope, AL Investigational Site, Fairhope
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Birmingham, AL Investigative Site 10012, Birmingham
  • Fairhope, AL Investigative Site 10004, Fairhope
  • Huntsville, AL Investigative Site 10026, Huntsville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • University of Alabama at Birmingham Hospital, Birmingham
Rekrutterer
Alder 18 til 100 · Alle køn · Opdateret 9. sep. 2026 · NCT06310031

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  • Heart Center Research, LLC, Huntsville
  • Mobile Infirmary Medical Center, Mobile
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07069738

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 156, Birmingham
RekruttererFase 2
Alder 30 til 84 · Alle køn · Opdateret 31. aug. 2026 · NCT07795814

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Eastern Shore Research Institute, LLC, Fairhope
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 27. aug. 2026 · NCT06793371

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Birmingham
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 20. aug. 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Alexander City
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 19. aug. 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Advanced Cardiovascular, LLC, Alexander City
  • Univ of Alabama Birmingham, Birmingham
  • Eastern Shore Rsrch Inst, LLC, Fairhope
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

  • Grandview Medical Group Research, LLC, Birmingham
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10004 Fairhope, AL Investigational Site, Fairhope
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. jul. 2026 · NCT06033950

Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function

  • Auburn University, Auburn
Rekrutterer
Alder 55 og opefter · Alle køn · Opdateret 25. mar. 2026 · NCT07489105

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

  • Eastern Shore Research Institute, Fairhope
RekruttererObservationsstudie
Alder 22 og opefter · Alle køn · Opdateret 26. mar. 2025 · NCT06378632

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

  • Heart Center Research, LLC, Huntsville
RekruttererFase 4
Alder 19 og opefter · Alle køn · Opdateret 29. jan. 2024 · NCT06218199

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.